Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension

By Suzuki Emilio Rintaro   Meirelles Franklin Luciana   da Silva Luciano José Basilio   Figueiredo Carlos R. L.   Agostini Netto Joao   Batista Wagner Duarte  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1799-1805

Informa Healthcare

Access to resources Recommend Favorite

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

By Day Douglas G.   Hollander David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1435-1442

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and patient tolerability of preservative‐free latanoprost compared with preservative prostaglandin analogs in patients with ocular hypertension or glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with openangle glaucoma or ocular hypertension

By Franks Wendy    

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1643-1649

Informa Healthcare

Access to resources Recommend Favorite

The effects of antioxidants on ocular blood flow in patients with glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e237-e241

John Wiley & Sons Inc

Access to resources Recommend Favorite